Sun Pharma Advanced Research Company Limited

Electricals|Engineering

SPARC-EQ: NSEBSE: 14788

Sun Pharma Advanced Research Company Limited (SPARC-EQ) live share price today at NSE / BSE

INR 193.86

+0.70 (0.36%)1 Day

Fri, 18 Sept 2026, 09:36 AM

About SPARC-EQ

Sun Pharma Advanced Research Company Ltd (SPARC) is an independent, innovation-driven biopharmaceutical company headquartered in India. Established as a demerged entity from Sun Pharmaceutical Industries in 2007, SPARC is focused on the discovery, development, and commercialization of new drugs and drug delivery systems across oncology, neuropsychiatry, ophthalmology, and dermatology. The company operates state-of-the-art research and development facilities that support preclinical, clinical, and regulatory activities, addressing global unmet medical needs.

52 Week Range

HighINR 289.00

LowINR 108.00

Current Signal

red

Open

INR 193.16

High

INR 198.60

Low

INR 192.39

Prev. Close

INR 193.16

Volume

4,82,910

Avg. Volume (7D)

6,37,145

Avg. Volume (10D)

7,02,905

Latest Signal

Sell

Sell Price

INR 196.2

Close Price

INR 196.01

Change

7.24%

Signal Date

2026-09-11

Hold

Pattern

Three Outside Up

Company Snapshot

CIN	L73100GJ2006PLC047837
Industry	Pharmaceuticals
Market Lot	1
Impact Cost	0.09%
Listing Date	17 Jul 2007
BC Record Date	BC 23/09/2021-29/09/2021
Registered Address	Plot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli - Vadodara Highway, Manjusar

Registrar

Name

MUFG Intime India Pvt. Ltd

Telephone

022 - 49186270

Website

www.in.mpms.mufg.com

Shareholding Pattern

Quarterly filing · 30 Jun 2026

Promoter & Promoter Group65.67%

Non-Institutions36.32%

Domestic Institutions0.00%

Foreign Institutions0.00%

Board of Directors

Mr.AnilRaghavanChief Executive Officer

Mr.Dilip Shantilal ShanghviNon-Executive - Non Independent Director-Chairperson related to Promoter

Mr.Ferzaan Nariman EngineerNon-Executive - Independent Director

Mr.Rajamannar ThennatiNon-Executive - Non Independent Director

Mr.Robert SpiegelNon-Executive - Independent Director

Mr.Venkasteswarlu JastiNon-Executive - Independent Director

Mrs.Bhavna Gautam DoshiNon-Executive - Independent Director

Mrs.Rekha WarriarNon-Executive - Independent Director

Mrs.Vidhi Dilip ShanghviNon-Executive - Non Independent Director

Ms.Kajal DamaniaCompany Secretary & Compliance Officer

Today Share Price

Sun Pharma Advanced Research Company Limited

Particulars	Details
Opening Price	INR 193.16
Previous Closing Price	INR 193.16
Volume of Sun Pharma Advanced Research Company Limited	4,82,910
Value of Share	—

Today NSE Share Price

Sun Pharma Advanced Research Company Limited

Particulars	Details
Live Share Price NSE India	INR 193.86
Previous Closing Price	INR 193.16
Open Price	INR 193.16
High	INR 198.60
Low	INR 192.39

Today BSE Share Price

Sun Pharma Advanced Research Company Limited

Particulars	Details
Live Share Price BSE India	INR 193.86
Previous Closing Price	INR 193.16
Open Price	INR 193.16
High	INR 198.60
Low	INR 192.39

Sun Pharma Advanced Research Company Limited

SPARC leverages a robust pipeline with multiple assets in various stages of clinical and pre-clinical development, primarily targeting regulated markets such as the US, Europe, and Japan. The company's business footprint includes strategic collaborations and licensing agreements with leading global pharmaceutical firms to maximize the reach and impact of its proprietary products and technology platforms.

Frequently Asked Questions – StockYaari Stock Page

Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.

Final Thoughts

Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.